title: Indinavir and systemic hypertension.
authors.affiliation: Infectious Diseases Department, General Hospital of Padua, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Cattelan
authors.forename: M
authors.initials: M
authors.lastname: Trevenzoli
authors.forename: L
authors.initials: L
authors.lastname: Sasset
authors.forename: L
authors.initials: L
authors.lastname: Rinaldi
authors.forename: V
authors.initials: V
authors.lastname: Balasso
authors.forename: P
authors.initials: P
authors.lastname: Cadrobbi
mesh_terms: D000328:Adult; D000368:Aged; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D019469:Indinavir / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors; D019469:Indinavir